Drawing for MIRALOE

USPTO serial 77325713

MIRALOE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BELENKER, ESTHER
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MIRALOE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Wm. Charles Saunders

WM. CHARLES SAUNDERS ASTRAZENECA PHARMACEUTICALS LP1800 CONCORD PIKE # OW2WILMINGTON, DE 19803-2902UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders or the nervous system, cardiovascular system and gastrointestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anesthesia, infection and inflammation; pharmaceutical preparations and substances for the treatment and prevention of diabetes; pharmaceutical preparations and substances for the treatment and prevention of oncological, urological and gynecological diseases and disordersABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2008MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Oct 22, 2008ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 22, 2008OP.TOPPOSITION TERMINATED NO. 999999—
Oct 22, 2008OP.DOPPOSITION DISMISSED NO. 999999—
Jul 10, 2008OP.IOPPOSITION INSTITUTED NO. 999999—
Apr 8, 2008ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 11, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 20, 2008NPUBNOTICE OF PUBLICATION—
Feb 4, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 4, 2008ALIEASSIGNED TO LIE—
Dec 25, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 24, 2007DOCKASSIGNED TO EXAMINER—
Nov 15, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance